Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review

Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Revenio Group Oyj (Revenio) is a provider of health tech screening devices related to ophthalmic diagnostic solutions. The company focuses on early detection of glaucoma, asthma, skin cancer, and macular degeneration. The company's major products include devices for detecting age-related eye diseases which include glaucoma, diabetic retinopathy, macular degeneration and cataracts. Revenio offers its products to ophthalmologists, opticians, and optometrists. The company has operations in Europe, America, and Asia. Revenio is headquartered in Vantaa, Finland.Revenio Group Oyj Key Recent Developments

Apr 25,2024: Revenio Group Release Interim Report for the Period 1 January – 31 March 2024
Mar 12,2024: Notice to Revenio Group Corporation's Annual General Meeting 2024
Feb 15,2024: Revenio Group Corporation: Financial Statements Release January 1 – December 31, 2023
Feb 14,2024: Revenio Group Announces Leadership Team Changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Revenio Group Oyj - Key Facts
Revenio Group Oyj - Key Employees
Revenio Group Oyj - Key Employee Biographies
Revenio Group Oyj - Major Products and Services
Revenio Group Oyj - History
Revenio Group Oyj - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Revenio Group Oyj - Business Description
Geographical Segment: Finland
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other
Performance
Geographical Segment: Other Europe
Performance
R&D Overview
Revenio Group Oyj - Corporate Strategy
Revenio Group Oyj - SWOT Analysis
SWOT Analysis - Overview
Revenio Group Oyj - Strengths
Revenio Group Oyj - Weaknesses
Revenio Group Oyj - Opportunities
Revenio Group Oyj - Threats
Revenio Group Oyj - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Revenio Group Oyj, Medical Equipment, Deals By Year, 2018 to YTD 2024
Revenio Group Oyj, Medical Equipment, Deals By Type, 2018 to YTD 2024
Revenio Group Oyj, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 25, 2024: Revenio Group Release Interim Report for the Period 1 January – 31 March 2024
Mar 12, 2024: Notice to Revenio Group Corporation's Annual General Meeting 2024
Feb 15, 2024: Revenio Group Corporation: Financial Statements Release January 1 – December 31, 2023
Feb 14, 2024: Revenio Group Announces Leadership Team Changes
Nov 21, 2023: Revenio Group Announces Financial Reporting and AGM in 2024
Oct 26, 2023: Revenio Group Corporation: Interim report January 1 - September 30, 2023
Oct 02, 2023: Marco Rizzardo appointed as Vice President, R&D and a member of the Leadership Team of Revenio Group
Aug 10, 2023: Revenio Group Announces Half-Year Financial Report 1 January–30 June 2023
Apr 27, 2023: Revenio Group Announces Interim report January 1-March 31, 2023
Mar 23, 2023: Revenio Group Corp. Decisions by the Annual General Meeting
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Revenio Group Oyj, Key Facts
Revenio Group Oyj, Key Employees
Revenio Group Oyj, Key Employee Biographies
Revenio Group Oyj, Major Products and Services
Revenio Group Oyj, History
Revenio Group Oyj, Subsidiaries
Revenio Group Oyj, Key Competitors
Revenio Group Oyj, Ratios based on current share price
Revenio Group Oyj, Annual Ratios
Revenio Group Oyj, Annual Ratios (Cont...1)
Revenio Group Oyj, Annual Ratios (Cont...2)
Revenio Group Oyj, Interim Ratios
Revenio Group Oyj, Medical Equipment, Deals By Year, 2018 to YTD 2024
Revenio Group Oyj, Medical Equipment, Deals By Type, 2018 to YTD 2024
Revenio Group Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Revenio Group Oyj, Performance Chart (2019 - 2023)
Revenio Group Oyj, Ratio Charts
Revenio Group Oyj, Medical Equipment, Deals By Year, 2018 to YTD 2024
Revenio Group Oyj, Medical Equipment, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings